KRAS and cancer: Furthermore, SIRT5 KO mice expressing KRAS or KRAS/p53 oncogenic mutations exhibitedan acceleration in tumor onset and significantly enhanced cancer cellproliferation in a caerulein-induced pancreatitis model in the absenceof caerulein.